Company News in the Life Science Industry

»

Reset 

Paragon 28® Launches Unique Option for Revising a Failed Synthetic Cartilage Implant (SCI)

ENGLEWOOD, Colo., Dec. 13, 2019 /PRNewswire/ -- Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery. Committed to creating tailored solutions to improve surgical outcomes, Paragon 28® has launched innovative products and instrumentation that help to streamline... Read more ››

By: PR Newswire Association LLC. - 14 Dec 2019

Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk

DUBLIN and BRIDGEWATER, N.J., Dec. 13, 2019 /PRNewswire/ -- Amarin Corporation plc (NASDAQ: AMRN) today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication and label expansion for VASCEPA(®) (icosapent ethyl) capsules. After more than a decade of development... Read more ››

By: PR Newswire Association LLC. - 14 Dec 2019

ProfNet Expert Alerts Available on Winter Health Habits, Raising an Aging Parent, Adult ADHD and more

NEW YORK, Dec. 13, 2019 /PRNewswire/ -- Below are experts from the ProfNet network who are available to discuss timely issues in your coverage area.

Read more ››
By: PR Newswire Association LLC. - 14 Dec 2019

Marinus Pharmaceuticals Announces Closing of $70 Million Public Offering of Common Stock and Concurrent Private Placement Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read more ››
By: GlobenewsWire - 13 Dec 2019
Related companies:  Marinus Pharmaceuticals, Inc.

Constellation Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares

Read more ››
By: GlobenewsWire - 13 Dec 2019
Related companies:  Constellation Pharmaceuticals, Inc.

T2 Biosystems Reports Granting of Inducement Awards

Read more ››
By: GlobenewsWire - 13 Dec 2019
Related companies:  T2 Biosystems, Inc.

Globus Medical Announces Board of Director Addition and Departure

Read more ››
By: GlobenewsWire - 13 Dec 2019
Related companies:  Globus Medical Inc.

Marinus Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: GlobenewsWire - 13 Dec 2019
Related companies:  Marinus Pharmaceuticals, Inc.

Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk

Read more ››
By: GlobenewsWire - 13 Dec 2019
Related companies:  Amarin Corporation plc

MDA Celebrates FDA Approval of Vyondys 53 for Treatment of DMD Amenable to Exon 53 Skipping

NEW YORK, Dec. 13, 2019 /PRNewswire/ -- The Muscular Dystrophy Association (MDA) today celebrated the decision by the US Food and Drug Administration (FDA) to grant accelerated marketing approval to golodirsen (Vyondys 53) for the treatment of Duchenne muscular dystrophy (DMD) in patients amenable... Read more ››

By: PR Newswire Association LLC. - 13 Dec 2019
Related companies:  Muscular Dystrophy Association Inc.

Takeda Partners with MiTest Health to Launch Innovative Disease Risk Prediction Tool to Redefine Crohn's Disease Management

LEXINGTON, Mass., Dec. 13, 2019 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A. (TSE: 4502) (NYSE:TAK) ("Takeda") and MiTest Health LLC ("MiTest"), a pioneering health technology company, today announced an exclusive partnership to optimize MiTest's personalized risk and outcome prediction tool... Read more ››

By: PR Newswire Association LLC. - 13 Dec 2019

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH PLAINFIELD, N.J., Dec. 13, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on December 9, 2019 it approved non-statutory stock options to purchase an aggregate of 59,150 shares of its common stock to 17 new employees. The awards were made pursuant to the... Read more ››

By: PR Newswire Association LLC. - 13 Dec 2019
Related companies:  PTC Therapeutics, Inc.

FDA approves use of drug to reduce risk of cardiovascular events in certain adult patient groups

SILVER SPRING, Md., Dec. 13, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the use of Vascepa (icosapent ethyl) as an adjunctive (secondary) therapy to reduce the risk of cardiovascular events among adults with elevated triglyceride levels (a type of fat in the blood)... Read more ››

By: PR Newswire Association LLC. - 13 Dec 2019
Related companies:  U.S. Food and Drug Administration

West Announces First-Quarter Dividend, Share Repurchase Program and Participation in Upcoming Investor Conference

EXTON, Pa., Dec. 13, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in... Read more ››

By: PR Newswire Association LLC. - 13 Dec 2019
Related companies:  West Pharmaceutical Services, Inc.

Garwood Medical Devices' $3m Series B Oversubscribed by $700,000

BUFFALO, N.Y., Dec. 13, 2019 /PRNewswire/ -- Garwood Medical Devices announced today that its Series B round closed 11/30/2019 at $3.7 million, over-subscribed by $700,000. The WNY Impact Investment Fund, who invested $500,000, 17 investors from Series A, and 18 other new investors all joined... Read more ››

By: PR Newswire Association LLC. - 13 Dec 2019
Related companies:  Garwood Medical Devices, LLC

Anixa Biosciences to Host Conference Call to Discuss Plans for 2020

SAN JOSE, Calif., Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing... Read more ››

By: PR Newswire Association LLC. - 13 Dec 2019
Related companies:  Anixa Biosciences Inc.

CHMP Issues Positive Opinion Recommending DARZALEX® (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma

Read more ››
By: GlobenewsWire - 13 Dec 2019
Related companies:  GeneNews Limited

BeiGene Announces Clinical Data on Investigational Anti-PD-1 Antibody Tislelizumab in Combination with Sitravatinib at European Society for Medical Oncology Immuno-Oncology (ESMO I-O) Congress 2019

Read more ››
By: GlobenewsWire - 13 Dec 2019
Related companies:  BeiGene, Ltd.

MediPharm Labs Receives First GMP Certification, Now Permitted to Serve Global Medical Cannabis Market

Read more ››
By: GlobenewsWire - 13 Dec 2019

Emerging Markets Report - Hoth Therapeutics on the Fast Track Toward Delivering Eczema Therapy Products to Market

Read more ››
By: GlobenewsWire - 13 Dec 2019
Related companies:  Hoth Therapeutics
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies